The Global Cardiovascular Catheters Market is estimated to garner a valuation of USD 9.66 billion by 2032 from USD 6.34 billion in 2023, delivering a CAGR of around 5.4% through the forecast period.
The market growth is driven by the growing prevalence of coronary disorders like angina pectoris and myocardial infarction, across the globe. According to the WHO, more than 17.9 million people die due to cardiovascular diseases (CVD) every year, and about half of all deaths from CVD are due to Coronary Heart Disease, and nearly a quarter is attributable to stroke.
Cardiac catheters are devices that are used for guiding and visualization of the coronary vasculature or to analyze the functioning of heart valves. The product is a thin, flexible tube that aids in performing cardiovascular procedures like angioplasty and stenting and is performed by guiding tools through the blood vessels in the body. Cardiac catheters are witnessing high demand as it offers a minimally invasive interventional procedure, opposed to open surgery.
Request a Sample@ https://www.qyresearchmedical.com/sample/119485
The cardiac catheter market size is expanding at a significant rate due to a rise in the incidence of heart diseases, cardiovascular problems with changing lifestyle patterns, bad dietary habits, and overconsumption of alcohol and tobacco products. This has further lead to arterial blockage and stroke, requiring surgeries. Increasing preference for minimally invasive procedures with better medical imaging will boost cardiac catheter market share. Moreover, the growing demand for interventional cardiac catheterization, along with technological innovations and advancement in sensor technology, will further reinforce cardiac catheters market trends through 2032.
In May 2019, The ACHA (Adult Congenital Heart Association) recently funded six research grants to carry forward research and development activities in the field of congenital heart disease. A supportive funding scenario will also supplement market revenue share over the forecast timeline.
However, factors such as high costs associated with cardiac catheterization procedures and lack of medical infrastructure in low-income economies may hamper production adoption.
By product type, the PTCA (Percutaneous transluminal coronary angioplasty) segment is anticipated to witness major growth over the forecast period. The growth can be attributed to increasing preference for the product as an interventional modality, as it is minimally invasive in nature and has been proven effective in treating heart attack, gangrene, and stroke.
In the regional landscape, North America is set to contribute significantly towards the cardiac catheter market share, growing at a CAGR of approximately 4% through the forecast period. The growth can be attributed to the growing prevalence of CVD in the region. According to the AHA (American Heart Association), atrial fibrillation (AF) affected nearly 2.7-6.1 million people in 2016 in the U.S., and the number is estimated to double by the end of 2050. Heart disease is the leading cause of mortality globally, and nearly 370,000 Americans lose their lives every year due to the disease.
Germany is estimated to contribute about USD 125 Million in the global revenue by the end of the analysis period due to favorable R&D funding for medical innovation supported by the European government.
Asia Pacific is estimated to witness the fastest growth over the analysis period due to the expanding geriatric population base and the growing prevalence of cardiovascular disease in the region, spurring demand for cardiac catheters in healthcare centers, hospitals, and surgical units. Japan’s cardiac catheters market is estimated to reach a valuation of over USD 480 Million by 2032. China’s cardiac catheters market is estimated to deliver a CAGR of nearly 8.5%, accounting for revenue generation of over USD 1.15 Billion by the end of the forecast period due to the presence of several aspiring industry players in the region.
Prominent players operating in the global cardiac catheters market are Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cook Group Inc., Medtronic Plc, Merit Medical Systems Inc., MicroPort Scientific Corp., and Terumo Corp, among others.
On 17th August 2022 – Royal Philips, a leading health technology company, introduced the first solid core pressure wire in the world for coronary artery interventional procedures, named OmniWire. The new ground-breaking product is likely to enable physicians to more easily maneuver the wire in the patient’s circulatory system for measuring blood pressure, vessel along with guiding the delivery of stents and catheters.
On 13th August 2022, Johnson & Johnson Medical Devices has announced that Biosense Webster’s QDot Micro radiofrequency ablation catheter received European CE mark approval.
Segments covered in this market study
This report about the Global Cardiac Catheters Market forecasts revenue growth at the global, regional, and country-level, provides an analysis of the industry trends in each of the sub-segments from 2023 to 2032. For the purpose of this study, the market is segmented on the basis of product type, end user, and region:
By Type (Revenue in USD Million; 2023–2032)
- Electrophysiology Catheters
- PTCA Balloons Catheters
- IVUS Catheters
- PTA Balloons Catheters
By End User (Revenue in USD Million; 2023–2032)
- Ambulatory Surgical Centers
By Region (Revenue in USD Million; 2023–2032)
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119485/1500
You can place an order or ask any questions, please feel free to contact firstname.lastname@example.org | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: